Acetazolamide for Injection, USP 500 mg (Mylan USA)

Each vial contains acetazolamide sodium lyophilised powder equivalent to 500 mg acetazolamide.

Indication:
For the adjunctive treatment of oedema due to congestive heart failure; drug-induced oedema; centrencephalic epilepsies (petit mal, unlocalised seizures); chronic simple (open-angle) glaucoma; secondary glaucoma; and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.

  • Strength: 500 mg lyophilised powder for injection
  • Package: Powder in vial
  • Status: Section 19A
  • Phebra Code: INJ257
  • Pack Size: 1 vial

Resources: